 The FDA has issued a black box warning for certain JAK inhibitors due to potential safety risks associated with their use. These drugs have been shown to increase the risk of certain cancers, as well as other serious side effects such as blood clots and infection. Patients taking these drugs should be monitored closely for any signs of these complications. This article was offered by Christine Samuel, Anna Kornman, Anisha Kambala, and others.